Inequity in Adoption of Advanced Diabetes Technologies Among Medicare Fee-for-service Beneficiaries

被引:14
作者
Wherry, Kael [1 ]
Zhu, Cyrus [1 ]
Vigersky, Robert A. [1 ]
机构
[1] Medtron Diabet, Northridge, CA 91325 USA
关键词
type; 1; diabetes; race-ethnicity; Medicare; insulin pump; continuous glucose monitoring; INSULIN PUMP THERAPY; ETHNIC DISPARITIES; TYPE-1; YOUTH; OUTCOMES; CHILDREN;
D O I
10.1210/clinem/dgab869
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Health inequity is often associated with race-ethnicity. Objective To determine the prevalence of insulin pump therapy and continuous glucose monitoring (CGM) among Medicare beneficiaries with type 1 diabetes (T1D) by race-ethnicity, and to compare diabetes-related technology users with nonusers. Design The prevalence of technology use (pump, CGM) was determined by race-ethnicity for enrollees in coverage years (CY) 2017-2019 in the Medicare fee-for-service database. Using CY2019 data, technology users were compared with nonusers by race-ethnicity, sex, average age, Medicare eligibility criteria, and visit to an endocrinologist. Setting Community Patients or Other Participants Beneficiaries with T1D and at least 1 inpatient or 2 outpatient claims in a CY. Intervention(s) Pump or CGM therapy, visit to an endocrinologist. Main Outcome Measure(s) Diabetes-related technology use by race-ethnicity groups. Results Between 2017 and 2019, CGM and insulin pump use increased among all groups. Prevalence of insulin pump use was < 5% for Black and Other beneficiaries yet increased from 14% to 18% among White beneficiaries. In CY2019, 57% of White patients used a pump compared with 33.1% of Black and 30.3% of Other patients (P < 0.001). Black patients were more likely than White patients to be eligible because of disability/end-stage renal disease or to be Medicare/Medicaid eligible (both P < 0.001), whether using technology or not. Significant race-ethnicity differences (P < 0.001) existed between technology users and nonusers for all evaluated factors except visiting an endocrinologist. Conclusions Significant race-ethnicity associated differences existed in T1D management. The gap in diabetic technology adoption between Black and White beneficiaries grew between 2017 and 2019.
引用
收藏
页码:E2177 / E2185
页数:9
相关论文
共 50 条
  • [41] The costs of dementia subtypes to California Medicare fee-for-service, 2015
    Chen, Yingjia
    Wilson, Leslie
    Kornak, John
    Dudley, R. Adams
    Merrilees, Jennifer
    Bonasera, Stephen J.
    Byrne, Christie M.
    Lee, Kirby
    Chiong, Winston
    Miller, Bruce L.
    Possin, Katherine L.
    ALZHEIMERS & DEMENTIA, 2019, 15 (07) : 899 - 906
  • [42] Hospital at Home services: An inventory of fee-for-service payments to inform Medicare reimbursement
    DeCherrie, Linda V.
    Wardlow, Liane
    Ornstein, Katherine A.
    Crowley, Christopher
    Lubetsky, Sara
    Stuck, Amy R.
    Siu, Albert L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (07) : 1982 - 1992
  • [43] Differences in the structure of CAHPS® measures among the Medicare fee-for-service, Medicare managed care, and privately insured populations
    Bender, RH
    Garfinkel, SA
    HEALTH SERVICES RESEARCH, 2001, 36 (03) : 489 - 508
  • [44] Colectomy among Fee-for-Service Medicare Enrollees Coded as DRG 330: A Potential Platform to Allow Consumer Cost Transparency?
    Hughes, Byron D.
    Sommerhalder, Christian
    Sieloff, E. Martin
    Williams, Kari E.
    Tyler, Douglas S.
    Senagore, Anthony J.
    HEALTHCARE, 2020, 8 (04)
  • [45] Long-Term Survival of Patients Undergoing Mitral Valve Repair and Replacement A Longitudinal Analysis of Medicare Fee-for-Service Beneficiaries
    Vassileva, Christina M.
    Mishkel, Gregory
    McNeely, Christian
    Boley, Theresa
    Markwell, Stephen
    Scaife, Steven
    Hazelrigg, Stephen
    CIRCULATION, 2013, 127 (18) : 1870 - 1876
  • [46] Prevalence and Cost of Care Cascades After Low-Value Preoperative Electrocardiogram for Cataract Surgery in Fee-for-Service Medicare Beneficiaries
    Ganguli, Ishani
    Lupo, Claire
    Mainor, Alexander J.
    Raymond, Stephanie
    Wang, Qianfei
    Orav, E. John
    Chang, Chiang-Hua
    Morden, Nancy E.
    Rosenthal, Meredith B.
    Colla, Carrie H.
    Sequist, Thomas D.
    JAMA INTERNAL MEDICINE, 2019, 179 (09) : 1211 - 1219
  • [47] State-Level Variations in the Utilization of Lung Cancer Screening Among Medicare Fee-for-Service Beneficiaries An Analysis of the 2015 to 2017 Physician and Other Supplier Data
    Liu, Bian
    Dharmarajan, Kavita
    Henschke, Claudia, I
    Taioli, Emanuela
    CHEST, 2020, 157 (04) : 1012 - 1020
  • [48] Economic burden of diabetes among medicare beneficiaries with cancer
    McDaniel, Cassidi C.
    Loh, F. Ellen
    Rockwell, Devan M.
    McDonald, Courtney P.
    Chou, Chiahung
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (02) : 142 - 151
  • [49] Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries
    Bruce E. Landon
    Alan M. Zaslavsky
    Jeffrey Souza
    John Z. Ayanian
    Journal of General Internal Medicine, 2018, 33 : 471 - 480
  • [50] Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries
    Landon, Bruce E.
    Zaslavsky, Alan M.
    Souza, Jeffrey
    Ayanian, John Z.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (04) : 471 - 480